Santa Clara, CA, United States of America

Naveen Bejugam

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 5.1

ph-index = 1

Forward Citations = 14(Granted Patents)


Location History:

  • Santa Clara, CA (US) (2016 - 2019)
  • South San Francisco, CA (US) (2024)

Company Filing History:


Years Active: 2016-2024

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Naveen Bejugam

Introduction

Naveen Bejugam is an accomplished inventor based in Santa Clara, CA. He has made significant contributions to the field of medicine, particularly in the treatment of hematological disorders. With a total of 3 patents, his work focuses on innovative dosing regimens and formulations for specific compounds.

Latest Patents

Naveen's latest patents include methods for treating sickle cell disease using 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde, also known as Compound 1. One patent details dosing regimens for administering this compound to patients. Another patent describes high strength and dispersible tablets containing Compound 1, which are designed to treat conditions such as sickle cell disease, idiopathic pulmonary fibrosis, and hypoxia.

Career Highlights

Throughout his career, Naveen has worked with notable companies in the pharmaceutical industry, including Global Blood Therapeutics, Inc. and Onyx Therapeutics, Inc. His expertise in drug formulation and treatment methodologies has positioned him as a valuable contributor to advancements in medical therapies.

Collaborations

Naveen has collaborated with professionals such as Sean Dalziel and Nazila Habibizad, enhancing the impact of his work through teamwork and shared expertise.

Conclusion

Naveen Bejugam's innovative contributions to medicine, particularly through his patents, demonstrate his commitment to improving treatment options for patients with serious health conditions. His work continues to influence the field and offers hope for better therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…